Aimei Health Technology (NASDAQ:AFJK) Stock Price Down 3.7% – Here’s Why

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) was down 3.7% on Thursday . The company traded as low as $40.00 and last traded at $40.5950. Approximately 6,179 shares changed hands during trading, an increase of 49% from the average daily volume of 4,152 shares. The stock had previously closed at $42.17.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Aimei Health Technology Price Performance

The firm has a 50-day moving average price of $37.36 and a 200 day moving average price of $37.51. The company has a market cap of $126.99 million, a price-to-earnings ratio of 222.56 and a beta of 0.46.

Aimei Health Technology (NASDAQ:AFJK) last posted its earnings results on Monday, May 4th. The company reported $0.02 EPS for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

Institutional investors and hedge funds have recently made changes to their positions in the company. Clear Street Group Inc. acquired a new position in shares of Aimei Health Technology in the third quarter valued at approximately $691,000. Berkley W R Corp grew its position in shares of Aimei Health Technology by 5.9% in the third quarter. Berkley W R Corp now owns 450,655 shares of the company’s stock valued at $5,101,000 after purchasing an additional 25,294 shares during the last quarter. Quarry LP grew its position in shares of Aimei Health Technology by 6.4% in the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of Aimei Health Technology in the fourth quarter valued at approximately $302,000. Finally, Geode Capital Management LLC acquired a new position in shares of Aimei Health Technology in the fourth quarter valued at approximately $413,000. Institutional investors and hedge funds own 45.58% of the company’s stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.